161 related articles for article (PubMed ID: 26795676)
1. Ruthenium(II) complexes of 1,3-thiazolidine-2-thione: Cytotoxicity against tumor cells and anti-Trypanosoma cruzi activity enhanced upon combination with benznidazole.
Corrêa RS; da Silva MM; Graminha AE; Meira CS; Santos JA; Moreira DR; Soares MB; Von Poelhsitz G; Castellano EE; Bloch C; Cominetti MR; Batista AA
J Inorg Biochem; 2016 Mar; 156():153-63. PubMed ID: 26795676
[TBL] [Abstract][Full Text] [Related]
2. Antiparasitic activities of novel ruthenium/lapachol complexes.
Barbosa MI; Corrêa RS; de Oliveira KM; Rodrigues C; Ellena J; Nascimento OR; Rocha VP; Nonato FR; Macedo TS; Barbosa-Filho JM; Soares MB; Batista AA
J Inorg Biochem; 2014 Jul; 136():33-9. PubMed ID: 24727183
[TBL] [Abstract][Full Text] [Related]
3. Non-mutagenic Ru(ii) complexes: cytotoxicity, topoisomerase IB inhibition, DNA and HSA binding.
da Silva MM; de Camargo MS; Correa RS; Castelli S; De Grandis RA; Takarada JE; Varanda EA; Castellano EE; Deflon VM; Cominetti MR; Desideri A; Batista AA
Dalton Trans; 2019 Oct; 48(39):14885-14897. PubMed ID: 31555783
[TBL] [Abstract][Full Text] [Related]
4. Ru(II)/clotrimazole/diphenylphosphine/bipyridine complexes: Interaction with DNA, BSA and biological potential against tumor cell lines and Mycobacterium tuberculosis.
Colina-Vegas L; Dutra JL; Villarreal W; de A Neto JH; Cominetti MR; Pavan F; Navarro M; Batista AA
J Inorg Biochem; 2016 Sep; 162():135-145. PubMed ID: 27383651
[TBL] [Abstract][Full Text] [Related]
5. Nitro/nitrosyl-ruthenium complexes are potent and selective anti-Trypanosoma cruzi agents causing autophagy and necrotic parasite death.
Bastos TM; Barbosa MI; da Silva MM; da C Júnior JW; Meira CS; Guimaraes ET; Ellena J; Moreira DR; Batista AA; Soares MB
Antimicrob Agents Chemother; 2014 Oct; 58(10):6044-55. PubMed ID: 25092707
[TBL] [Abstract][Full Text] [Related]
6. On the Cytotoxicity of Chiral Ruthenium Complexes Containing Sulfur Amino Acids against Breast Tumor Cells (MDA-231 and MCF-7).
Leite CM; de Araujo-Neto JH; Corrêa RS; Colina-Vegas L; Martínez-Otero D; Martins PR; Silva CG; Batista AA
Anticancer Agents Med Chem; 2021; 21(9):1172-1182. PubMed ID: 32838726
[TBL] [Abstract][Full Text] [Related]
7. Coordination of nitro-thiosemicarbazones to ruthenium(II) as a strategy for anti-trypanosomal activity improvement.
Rodrigues C; Batista AA; Ellena J; Castellano EE; Benítez D; Cerecetto H; González M; Teixeira LR; Beraldo H
Eur J Med Chem; 2010 Jul; 45(7):2847-53. PubMed ID: 20363536
[TBL] [Abstract][Full Text] [Related]
8. Ru/Fe bimetallic complexes: Synthesis, characterization, cytotoxicity and study of their interactions with DNA/HSA and human topoisomerase IB.
Takarada JE; Guedes APM; Correa RS; Silveira-Lacerda EP; Castelli S; Iacovelli F; Deflon VM; Batista AA; Desideri A
Arch Biochem Biophys; 2017 Dec; 636():28-41. PubMed ID: 29107586
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells.
Popolin CP; Reis JPB; Becceneri AB; Graminha AE; Almeida MAP; Corrêa RS; Colina-Vegas LA; Ellena J; Batista AA; Cominetti MR
PLoS One; 2017; 12(9):e0183275. PubMed ID: 28898246
[TBL] [Abstract][Full Text] [Related]
10. Ru(II)-Naphthoquinone complexes with high selectivity for triple-negative breast cancer.
Oliveira KM; Peterson EJ; Carroccia MC; Cominetti MR; Deflon VM; Farrell NP; Batista AA; Correa RS
Dalton Trans; 2020 Nov; 49(45):16193-16203. PubMed ID: 32329497
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, characterization, X-ray structure and in vitro antimycobacterial and antitumoral activities of Ru(II) phosphine/diimine complexes containing the "SpymMe2" ligand, SpymMe2=4,6-dimethyl-2-mercaptopyrimidine.
do Nascimento FB; Von Poelhsitz G; Pavan FR; Sato DN; Leite CQ; Selistre-de-Araújo HS; Ellena J; Castellano EE; Deflon VM; Batista AA
J Inorg Biochem; 2008 Sep; 102(9):1783-9. PubMed ID: 18614238
[TBL] [Abstract][Full Text] [Related]
12. New ruthenium complexes containing salicylic acid and derivatives induce triple-negative tumor cell death via the intrinsic apoptotic pathway.
Graminha AE; Popolin C; Honorato de Araujo-Neto J; Correa RS; de Oliveira KM; Godoy LR; Vegas LC; Ellena J; Batista AA; Cominetti MR
Eur J Med Chem; 2022 Dec; 243():114772. PubMed ID: 36191406
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo antitumor activity of a novel carbonyl ruthenium compound, the ct-[RuCl(CO)(dppb)(bipy)]PF-6[dppb=1,4-bis(diphenylphosphine)butane and bipy=2,2'-bipyridine].
Carnizello AP; Barbosa MI; Martins M; Ferreira NH; Oliveira PF; Magalhães GM; Batista AA; Tavares DC
J Inorg Biochem; 2016 Nov; 164():42-48. PubMed ID: 27613330
[TBL] [Abstract][Full Text] [Related]
14. Cis-[RuCl(BzCN)(N-N)(P-P)]PF6 complexes: Synthesis and in vitro antitumor activity: (BzCN=benzonitrile; N-N=2,2'-bipyridine; 1,10-phenanthroline; P-P=1,4-bis(diphenylphosphino) butane, 1,2-bis(diphenylphosphino)ethane, or 1,1'-(diphenylphosphino)ferrocene).
Pereira Fde C; Lima BA; de Lima AP; Pires WC; Monteiro T; Magalhães LF; Costa W; Graminha AE; Batista AA; Ellena J; Siveira-Lacerda Ede P
J Inorg Biochem; 2015 Aug; 149():91-101. PubMed ID: 25873134
[TBL] [Abstract][Full Text] [Related]
15. Ruthenium(II) phosphine/diimine/picolinate complexes: inorganic compounds as agents against tuberculosis.
Pavan FR; Poelhsitz GV; Barbosa MI; Leite SR; Batista AA; Ellena J; Sato LS; Franzblau SG; Moreno V; Gambino D; Leite CQ
Eur J Med Chem; 2011 Oct; 46(10):5099-107. PubMed ID: 21875763
[TBL] [Abstract][Full Text] [Related]
16. Ru(II) complexes containing uracil nucleobase analogs with cytotoxicity against tumor cells.
Correa RS; Bomfim LM; Oliveira KM; Moreira DRM; Soares MBP; Ellena J; Bezerra DP; Batista AA
J Inorg Biochem; 2019 Sep; 198():110751. PubMed ID: 31220757
[TBL] [Abstract][Full Text] [Related]
17. Searching for new chemotherapies for tropical diseases: ruthenium-clotrimazole complexes display high in vitro activity against Leishmania major and Trypanosoma cruzi and low toxicity toward normal mammalian cells.
Martínez A; Carreon T; Iniguez E; Anzellotti A; Sánchez A; Tyan M; Sattler A; Herrera L; Maldonado RA; Sánchez-Delgado RA
J Med Chem; 2012 Apr; 55(8):3867-77. PubMed ID: 22448965
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the biological potential of ruthenium(II) complexes with cinnamic acid.
Graminha AE; Honorato J; Dulcey LL; Godoy LR; Barbosa MF; Cominetti MR; Menezes AC; Batista AA
J Inorg Biochem; 2020 May; 206():111021. PubMed ID: 32163810
[TBL] [Abstract][Full Text] [Related]
19. Metal-drug synergy: new ruthenium(II) complexes of ketoconazole are highly active against Leishmania major and Trypanosoma cruzi and nontoxic to human or murine normal cells.
Iniguez E; Sánchez A; Vasquez MA; Martínez A; Olivas J; Sattler A; Sánchez-Delgado RA; Maldonado RA
J Biol Inorg Chem; 2013 Oct; 18(7):779-90. PubMed ID: 23881220
[TBL] [Abstract][Full Text] [Related]
20. Ruthenium(II) Phosphine/Mercapto Complexes: Their in Vitro Cytotoxicity Evaluation and Actions as Inhibitors of Topoisomerase and Proteasome Acting as Possible Triggers of Cell Death Induction.
Ribeiro GH; Guedes APM; de Oliveira TD; de Correia CRSTB; Colina-Vegas L; Lima MA; Nóbrega JA; Cominetti MR; Rocha FV; Ferreira AG; Castellano EE; Teixeira FR; Batista AA
Inorg Chem; 2020 Oct; 59(20):15004-15018. PubMed ID: 32997499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
